NeOnc has formally notified the FDA that the Phase 1 dose-escalation portion of the NEO212-01 Phase 1/2 clinical trial has reached Maximum Tolerated Dose (MTD) at Cohort 5 (810 mg, Days 1–5, 28-day ...
Researchers have discovered a natural brain cleansing mechanism that helps individual neurons remove toxic tau protein, a key factor in Alzheimer's disease. This was reported on March 3 in the journal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results